Managed Care Weekly Digest
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Weekly Digest
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiotensins
Diabetic Beneficiaries Receive Extra Push to Stay Healthy
June 18th, 2007
For many people with diabetes, kidney damage and cardiovascular complications are devastating side effects of the disease. Fortunately, two classes of medications - ACEI (Angiotensin Converting Enzyme Inhibitors) or ARB (Angiotensin Receptor Blockers) - have been proven to help reduce the progression of kidney and cardiovascular problems. To help keep its diabetic beneficiaries healthy, MemberHealth's CCRx Medicare Part D Prescription Drug Plan recently started working with physicians to ensure they prescribe ACEIs or ARBs for beneficiaries with diabetes. As a result, 68 percent of CCRx's beneficiaries with diabetes are now taking an ACEI or ARB. ...
Source: Managed Care Weekly Digest (2007-06-18)
|
